Your browser doesn't support javascript.
loading
Adrenal insufficiency is a contraindication for omalizumab therapy in mast cell activation disease: risk for serum sickness.
Molderings, G J; Dumoulin, F L; Homann, J; Sido, B; Textor, J; Mücke, M; Qagish, G J; Barion, R; Raithel, M; Klingmüller, D; Schäfer, V S; Hertfelder, H J; Berdel, D; Tridente, G; Weinstock, L B; Afrin, L B.
Afiliação
  • Molderings GJ; Institute of Human Genetics, University Hospital Bonn, Venusberg-Campus 1, D-53127, Bonn, Germany. molderings@uni-bonn.de.
  • Dumoulin FL; Department of Internal Medicine, Gemeinschaftskrankenhaus Bonn, Bonn, Germany.
  • Homann J; Department of Internal Medicine, Gemeinschaftskrankenhaus Bonn, Bonn, Germany.
  • Sido B; Department of General and Visceral Surgery, Gemeinschaftskrankenhaus Bonn, Bonn, Germany.
  • Textor J; Department of Radiology, Gemeinschaftskrankenhaus Bonn, Bonn, Germany.
  • Mücke M; Center for Rare Diseases, University Hospital Bonn, Bonn, Germany.
  • Qagish GJ; Medical Office for Internal Medicine, Meckenheim, Germany.
  • Barion R; Medical Office for Diabetology, Niederkassel, Rheidt, Germany.
  • Raithel M; Malteser Waldkrankenhaus St. Marien, Medical Clinic II, Erlangen, Germany.
  • Klingmüller D; Department of Endocrinology, University Hospital Bonn, Bonn, Germany.
  • Schäfer VS; Department of Rheumatology and Clinical Immunology, Clinic for Internal Medicine III, University Hospital Bonn, Bonn, Germany.
  • Hertfelder HJ; Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany.
  • Berdel D; Marien Hospital Wesel, Wesel, Germany.
  • Tridente G; University of Verona, Verona, Italy.
  • Weinstock LB; Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, 63141, USA.
  • Afrin LB; Armonk Integrative Medicine, Hematology/Oncology, Purchase, New York, NY, 10577, USA.
Naunyn Schmiedebergs Arch Pharmacol ; 393(9): 1573-1580, 2020 09.
Article em En | MEDLINE | ID: mdl-32377770
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença do Soro / Mastocitose / Insuficiência Adrenal / Omalizumab / Fatores Imunológicos / Mastócitos Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Naunyn Schmiedebergs Arch Pharmacol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença do Soro / Mastocitose / Insuficiência Adrenal / Omalizumab / Fatores Imunológicos / Mastócitos Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Naunyn Schmiedebergs Arch Pharmacol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Alemanha